Performance of GILD Gilead Sciences | -14.6% in 12m
Compare GILD with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Gilead Sciences with its related Sector/Index XBI
Performance Duell GILD vs XBI
| TimeFrame | GILD | XBI |
|---|---|---|
| 1 Day | 1.17% | 0.67% |
| 1 Week | -0.61% | 5.92% |
| 1 Month | -5.81% | 0.44% |
| 3 Months | -14.8% | 0.91% |
| 6 Months | -17.7% | 29.64% |
| 12 Months | -14.6% | 6.11% |
| YTD | -20.5% | 0.39% |
| Rel. Perf. 1m | -0.61 | |
| Rel. Perf. 3m | -2.46 | |
| Rel. Perf. 6m | -4.69 | |
| Rel. Perf. 12m | -2.25 |
Is Gilead Sciences a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Gilead Sciences (NASDAQ:GILD) is currently (May 2024)
a good stock to buy. It has a ValueRay Fundamental Rating of 70.07 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GILD as of May 2024 is 71.00. This means that GILD is currently overvalued and has a potential downside of 8.33% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GILD as of May 2024 is 71.00. This means that GILD is currently overvalued and has a potential downside of 8.33% (Sold with Premium).
Is GILD a buy, sell or hold?
- Strong Buy: 8
- Buy: 7
- Hold: 16
- Sell: 0
- Strong Sell: 1
Values above 0%: GILD is performing better - Values below 0%: GILD is underperforming
Compare GILD with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.89% | -5.45% | -37.07% | -41.58% |
| US NASDAQ 100 | QQQ | -2.34% | -5.76% | -37.36% | -51.84% |
| US Dow Jones Industrial 30 | DIA | -1.82% | -5.76% | -32.63% | -32.17% |
| German DAX 40 | DBXD | -0.87% | -5.80% | -37.47% | -28.01% |
| UK FTSE 100 | ISFU | -1.42% | -9.41% | -31.61% | -23.33% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.81% | -9.21% | -19.54% | -3.41% |
| Hongkong Hang Seng | HSI | -5.29% | -14.64% | -16.70% | -0.47% |
| Japan Nikkei 225 | EXX7 | -3.23% | -3.68% | -33.41% | -34.27% |
| India NIFTY 50 | INDA | -0.31% | -6.48% | -36.17% | -41.32% |
| Brasil Bovespa | EWZ | -2.44% | -7.44% | -22.21% | -33.86% |
GILD Gilead Sciences vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -3.29% | -4.33% | -38.94% | -55.26% |
| Consumer Discretionary | XLY | -0.50% | -6.35% | -30.19% | -37.69% |
| Consumer Staples | XLP | -0.73% | -7.95% | -29.57% | -15.82% |
| Energy | XLE | 2.60% | -0.94% | -28.46% | -34.89% |
| Financial | XLF | -1.37% | -4.61% | -40.66% | -43.88% |
| Health Care | XLV | -1.30% | -4.54% | -28.80% | -22.16% |
| Industrial | XLI | -1.04% | -4.49% | -41.09% | -41.29% |
| Materials | XLB | -0.39% | -2.90% | -33.76% | -29.97% |
| Real Estate | XLRE | -1.04% | -2.29% | -26.46% | -17.01% |
| Technology | XLK | -2.72% | -5.07% | -36.65% | -51.18% |
| Utilities | XLU | -3.10% | -11.33% | -31.08% | -17.62% |
| Aerospace & Defense | XAR | -3.81% | -8.55% | -36.04% | -40.66% |
| Biotech | XBI | -6.53% | -6.25% | -47.30% | -20.69% |
| Homebuilder | XHB | -2.89% | -4.22% | -57.96% | -66.84% |
| Retail | XRT | -2.09% | -5.29% | -39.14% | -37.77% |
Does Gilead Sciences outperform its market, is GILD a Sector Leader?
No, over the last 12 months Gilead Sciences (GILD) made -14.58%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.11%.
Over the last 3 months GILD made -14.81%, while XBI made 0.91%.
No, over the last 12 months Gilead Sciences (GILD) made -14.58%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.11%.
Over the last 3 months GILD made -14.81%, while XBI made 0.91%.
| Period | GILD | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -5.81% | 0.44% | -0.36% |
| 3 Months | -14.81% | 0.91% | 4.90% |
| 12 Months | -14.58% | 6.11% | 27.00% |